Therma Bright Inc. provided the following update on its Brazilian clinical study of its innovative 15- minute COVID-19 antigen saliva test. Following last week's announcement on securing K-One MediTech as the Asia-based manufacturer, the company has finalized the AcuVid test kit specifications and is initiating the clinical evaluation study of this simple, easy-to-use and cost-effective kit, and anticipates a full update on the progress from its Brazilian partners at Federal University of Minas Gerais within the next 8 to 12 days. The company looks to provide a further update upon receipt of the clinical study results. In the meantime, its manufacturing and sales teams continue to prepare for production and distribution of the test.